Free Trial

Indivior (INVVY) News Today

Indivior logo
$21.85 -0.40 (-1.82%)
As of 06/9/2023
Indivior price target lowered to $13 from $16 at Piper Sandler
Indivior CEO Mark Crossley to step down, Joe Ciaffoni to succeed
Indivior (INDV) Gets a Buy from Jefferies
Indivior announces FDA approval for Sublocade label changes
Indivior PLC (INDV) Q4 2024 Earnings Call Transcript
Piper Sandler Reaffirms Their Buy Rating on Indivior (INDV)
Indivior Completes $100M Share Repurchase Program
Indivior PLC Updates Total Voting Rights
Indivior initiated with a Buy at Rodman & Renshaw
Indivior Director Acquires Significant Shareholding
Indivior Advances Share Repurchase Initiative
Remove Ads
Get Indivior News Delivered to You Automatically

Sign up to receive the latest news and ratings for INVVY and its competitors with MarketBeat's FREE daily newsletter.

INVVY Media Mentions By Week

INVVY Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

INVVY
News Sentiment

0.58

0.75

Average
Medical
News Sentiment

INVVY News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

INVVY Articles
This Week

3

2

INVVY Articles
Average Week

Remove Ads
Get Indivior News Delivered to You Automatically

Sign up to receive the latest news and ratings for INVVY and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (OTCMKTS:INVVY) was last updated on 3/13/2025 by MarketBeat.com Staff
From Our Partners